-
1
-
-
0032572913
-
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
-
Besarab A, Bolton WK, Browne JK et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998; 339:584-590
-
(1998)
N Engl J Med
, vol.339
, pp. 584-590
-
-
Besarab, A.1
Bolton, W.K.2
Browne, J.K.3
-
2
-
-
33750983605
-
CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease
-
Singh AK, Szczech L, Tang KL et al. CHOIR Investigators. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098
-
(2006)
N Engl J Med
, vol.355
, pp. 2085-2098
-
-
Singh, A.K.1
Szczech, L.2
Tang, K.L.3
-
3
-
-
33751002326
-
CREATE Investigators. Normalization of hemoglobin level in. patients with chronic kidney disease and anemia
-
Drueke TB, Locatelli F, Clyne N et al. CREATE Investigators. Normalization of hemoglobin level in. patients with chronic kidney disease and anemia. N Engl J Med 2006; 355:2071-2084
-
(2006)
N Engl J Med
, vol.355
, pp. 2071-2084
-
-
Drueke, T.B.1
Locatelli, F.2
Clyne, N.3
-
4
-
-
33846682340
-
Understanding recent haemoglobin trials in CKD: Methods and lesson learned from CREATE and CHOIR
-
Levin A. Understanding recent haemoglobin trials in CKD: Methods and lesson learned from CREATE and CHOIR. Nephrol Dial Transplant 2007; 22: 309-312
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 309-312
-
-
Levin, A.1
-
5
-
-
0030921662
-
-
NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 1997; 30[4 Suppl 3]:S192-S240
-
NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 1997; 30[4 Suppl 3]:S192-S240
-
-
-
-
6
-
-
0035228407
-
-
NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. POWER Study Group. Am J Kidney Dis 2001; 37 [1 Suppl 1]: S182-S238
-
NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. POWER Study Group. Am J Kidney Dis 2001; 37 [1 Suppl 1]: S182-S238
-
-
-
-
7
-
-
2942744923
-
POWER study group. Once-weekly epoetin alfa for treating the anemia of chronic kidney disease
-
Provenzano R, Garcia-Mayol L, Suchinda P et al. POWER study group. Once-weekly epoetin alfa for treating the anemia of chronic kidney disease. Clin Nephrol 2000; 61: 392-405
-
(2000)
Clin Nephrol
, vol.61
, pp. 392-405
-
-
Provenzano, R.1
Garcia-Mayol, L.2
Suchinda, P.3
-
8
-
-
23144460027
-
PROMPT Study Group. Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: The PROMPT study
-
Provenzano R, Bhaduri S, Singh AK. PROMPT Study Group. Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: The PROMPT study. Clin Nephrol 2005; 64: 113-123
-
(2005)
Clin Nephrol
, vol.64
, pp. 113-123
-
-
Provenzano, R.1
Bhaduri, S.2
Singh, A.K.3
-
9
-
-
9144239992
-
Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): Results of a randomized clinical trial
-
Roger SD, McMahon LP, Clarkson A et al. Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): Results of a randomized clinical trial. J Am Soc Nephrol 2004; 15: 148-156
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 148-156
-
-
Roger, S.D.1
McMahon, L.P.2
Clarkson, A.3
-
10
-
-
33745050664
-
Dosing patterns, hematologic outcomes and costs of erythropoietic agents in predialysis chronic kidney disease patients with anemia
-
Papatheofanis FJ, McKenzie RS, Mody SH, Suruki RY, Piech CT. Dosing patterns, hematologic outcomes and costs of erythropoietic agents in predialysis chronic kidney disease patients with anemia. Curr Med Res Opin 2006; 22: 837-842
-
(2006)
Curr Med Res Opin
, vol.22
, pp. 837-842
-
-
Papatheofanis, F.J.1
McKenzie, R.S.2
Mody, S.H.3
Suruki, R.Y.4
Piech, C.T.5
-
11
-
-
23144442156
-
Extended epoetin alfa dosing in chronic kidney disease patients: A retrospective review
-
Epub 28 June
-
Germain M, Ram CV, Bhaduri S, Tang KL, Klausner M, Curzi M. Extended epoetin alfa dosing in chronic kidney disease patients: A retrospective review. Nephrol Dial Transplant 2005; 20: 2146-2152. Epub 28 June 2005
-
(2005)
Nephrol Dial Transplant 2005
, vol.20
, pp. 2146-2152
-
-
Germain, M.1
Ram, C.V.2
Bhaduri, S.3
Tang, K.L.4
Klausner, M.5
Curzi, M.6
-
12
-
-
34547844636
-
-
Ortho Biotech. Clinical Study Report. http://download.veritasmedicine.com/PDF/CR000588_CSR.pdf
-
Ortho Biotech. Clinical Study Report. http://download.veritasmedicine.com/PDF/CR000588_CSR.pdf
-
-
-
-
13
-
-
33846669860
-
Mortality and target haemoglobin concentrations in anemia patients with chronic kidney disease treated with erythropoietin: A meta-analysis
-
Phrommintikul A, Haas SJ, Elsik M, Klum H. Mortality and target haemoglobin concentrations in anemia patients with chronic kidney disease treated with erythropoietin: A meta-analysis. Lancet 2007; 369: 381-388
-
(2007)
Lancet
, vol.369
, pp. 381-388
-
-
Phrommintikul, A.1
Haas, S.J.2
Elsik, M.3
Klum, H.4
-
14
-
-
33846677380
-
Haemoglobin targets: We were wrong, time to move on
-
Strippoli GF, Tognoni S, Navaneethan SD, Nicolucci A, Craig JC. Haemoglobin targets: We were wrong, time to move on. Lancet 2007; 369: 346-350
-
(2007)
Lancet
, vol.369
, pp. 346-350
-
-
Strippoli, G.F.1
Tognoni, S.2
Navaneethan, S.D.3
Nicolucci, A.4
Craig, J.C.5
-
15
-
-
0027934302
-
Interim analysis: The alpha spending function approach
-
discussion 1353-1356
-
DeMets DL, Lan KK. Interim analysis: The alpha spending function approach. Stat Med 1994; 13: 1341-1352; discussion 1353-1356
-
(1994)
Stat Med
, vol.13
, pp. 1341-1352
-
-
DeMets, D.L.1
Lan, K.K.2
-
16
-
-
33845641241
-
Haemoglobin and haematocrit targets for the anaemia of chronic renal disease
-
CD003967
-
Strippoli GF, Manno C, Schena FP, Craig JC, Paoletti E, Cannella G. Haemoglobin and haematocrit targets for the anaemia of chronic renal disease. Cochrane Database Syst Rev 2003; 1; CD003967
-
(2003)
Cochrane Database Syst Rev
, pp. 1
-
-
Strippoli, G.F.1
Manno, C.2
Schena, F.P.3
Craig, J.C.4
Paoletti, E.5
Cannella, G.6
|